Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129686 · ClinicalTrials.gov registry record · NA
A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02129686 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 57 participants.
The verdict
NCT02129686, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This study is being done to evaluate the potential benefits of using acupuncture to reduce symptoms of tingling, burning, numbness and pain in the hands and feet of women with peripheral neuropathy after completion of chemotherapy for breast cancer.
Interventions
- PROCEDURE Immediate Acupuncture Group
- PROCEDURE Delayed Acupuncture Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129686
The ClinicalTrials.gov registry entry for NCT02129686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Immediate Acupuncture Group is the first listed.
NCT02129686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02129686 about?
NCT02129686 is a clinical study titled "A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients". This study is being done to evaluate the potential benefits of using acupuncture to reduce symptoms of tingling, burning, numbness and pain in the hands and feet of women with peripheral neuropathy after completion of chemotherapy for breast cancer.
What is the current status of trial NCT02129686?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2014-06-01. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT02129686?
The interventions under investigation include: Immediate Acupuncture Group (PROCEDURE), Delayed Acupuncture Group (PROCEDURE).
Who is sponsoring clinical trial NCT02129686?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.